Title: Efficacy of a modified sequential therapy including bismuth subcitrate as first-line therapy to eradicate Helicobacter pylori in a Turkish population.
Journal: Helicobacter 20121201
Title: Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pylori.
Journal: World journal of gastroenterology 20120828
Title: Survey of anaemia and Helicobacter pylori infection in adolescent girls in Suihua, China and enhancement of iron intervention effects by H. pylori eradication.
Journal: The British journal of nutrition 20120701
Title: Doxycycline-based quadruple regimen versus routine quadruple regimen for rescue eradication of Helicobacter pylori: an open-label control study in Chinese patients.
Journal: Singapore medical journal 20120401
Title: Bismuth ions inhibit the biological activity of non-amidated gastrins in vivo.
Journal: Biochemical pharmacology 20120215
Title: A comparison between sequential therapy and a modified bismuth-based quadruple therapy for Helicobacter pylori eradication in Iran: a randomized clinical trial.
Journal: Helicobacter 20120201
Title: Is quadruple therapy the new triple therapy for H pylori?
Journal: Canadian family physician Medecin de famille canadien 20120101
Title: Quadruple therapy with medications containing either rufloxacin or furazolidone as a rescue regimen in the treatment of Helicobacter pylori-infected dyspepsia patients: a randomized pilot study.
Journal: Helicobacter 20110801
Title: Helicobacter pylori infection: a randomized, controlled study comparing 2 rescue therapies after failure of standard triple therapies.
Journal: Medicine 20110501
Title: Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study.
Journal: Alimentary pharmacology & therapeutics 20110401
Title: Studies of distribution and recurrence of Helicobacter spp. gastric mucosa of dogs after triple therapy.
Journal: Acta cirurgica brasileira 20110401
Title: Quadruple or triple therapy to eradicate H pylori.
Journal: Lancet (London, England) 20110312
Title: Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial.
Journal: Lancet (London, England) 20110312
Title: [Rifaximin in combined treatment of the Helicobacter pylori infection in childhood].
Journal: Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20110101
Title: [Helicobacter pylori: what schemes of eradication are essential today?].
Journal: Terapevticheskii arkhiv 20110101
Title: Considerable use of furazolidone in Iran.
Journal: Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20101001
Title: Comparison of the efficacy of triple versus quadruple therapy on the eradication of Helicobacter pylori and antibiotic resistance.
Journal: Journal of digestive diseases 20101001
Title: Case of the month. MALT lymphoma.
Journal: JAAPA : official journal of the American Academy of Physician Assistants 20101001
Title: Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori.
Journal: Journal of gastrointestinal cancer 20100901
Title: Helicobacter pylori infection.
Journal: The New England journal of medicine 20100805
Title: High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
Journal: Helicobacter 20100601
Title: Short-duration furazolidone therapy in combination with amoxicillin, bismuth subcitrate, and omeprazole for eradication of Helicobacter pylori.
Journal: Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20100101
Title: Parallel on-line detection of a methylbismuth species by hyphenated GC/EI-MS/ICP-MS technique as evidence for bismuth methylation by human hepatic cells.
Journal: Metallomics : integrated biometal science 20100101
Title: Effect of bismuth citrate, lactose, and organic acid on necrotic enteritis in broilers.
Journal: Poultry science 20091101
Title: Peptic ulcer disease.
Journal: Lancet (London, England) 20091024
Title: A systematic review of treating Helicobacter pylori infection with Traditional Chinese Medicine.
Journal: World journal of gastroenterology 20091007
Title: Furazolidone, co-amoxiclav, colloidal bismuth subcitrate, and esomeprazole for patients who failed to eradicate Helicobacter pylori with triple therapy.
Journal: Digestive diseases and sciences 20090901
Title: Efficacy of the standard quadruple therapy versus triple therapies containing proton pump inhibitor plus amoxicillin and clarithromycin or amoxicillin-clavulanic acid and metronidazole for Helicobacter pylori eradication in children.
Journal: Digestive diseases and sciences 20090801
Title: High efficacy of bismuth subcitrate for Helicobacter pylori eradication in pangastritis.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20090801
Title: Oxidative stress in Helicobacter pylori infection: does supplementation with vitamins C and E increase the eradication rate?
Journal: Helicobacter 20090801
Title: Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial.
Journal: The Journal of antimicrobial chemotherapy 20090501
Title: Determination of trimethylbismuth in the human body after ingestion of colloidal bismuth subcitrate.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20090201
Title: Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
Journal: The American journal of gastroenterology 20090101
Title: Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial.
Journal: Wiener klinische Wochenschrift 20090101
Title: [Combined treatment of gastric ulcers induced by nonsteroid antiinflammatory drugs. Results of 4-week population-based controlled trial of efficacy of proton pump inhibitor combination with tripotassium bismuth dicitrate].
Journal: Terapevticheskii arkhiv 20090101
Title: [Rifaksimin in complex treatment of Helicobacter pylori infection in children (a pilot study)].
Journal: Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20090101
Title: Failure of Helicobacter pylori treatment after regimes containing clarithromycin: new practical therapeutic options.
Journal: Helicobacter 20081201
Title: Quadruple therapy with furazolidone for retreatment in patients with peptic ulcer disease.
Journal: World journal of gastroenterology 20081028
Title: Treatment of Helicobacter pylori in surgical practice: a randomised trial of triple versus quadruple therapy in a rural district general hospital.
Journal: World journal of gastroenterology 20080628
Title: Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures.
Journal: European journal of clinical investigation 20080601
Title: [Efficacy of levofloxacin-based triple therapy as second-line Helicobacter pylori eradication].
Journal: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080501
Title: Diclofenac-bismuth complex: synthesis, physicochemical, and biological evaluation.
Journal: Drug development and industrial pharmacy 20080401
Title: Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients.
Journal: Alimentary pharmacology & therapeutics 20080215
Title: Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
Journal: Journal of gastroenterology and hepatology 20080101
Title: [Bismuth preparations in the treatment of patients with gastric and duodenal ulcer disease].
Journal: Klinicheskaia meditsina 20080101
Title: [The use of bismuth tripotassium dicitrate (De-Nol), a promising line of pathogenetic therapy for irritated bowel syndrome with diarrhea].
Journal: Klinicheskaia meditsina 20080101
Title: [Clinical response to de-nol in peptic ulcer patients].
Journal: Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20080101
Title: Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy.
Journal: Helicobacter 20071201
Title: Effects of H pylori therapy on erythrocytic and iron parameters in iron deficiency anemia patients with H pylori-positive chronic gastristis.
Journal: World journal of gastroenterology 20071028
Title: The protective roles of some lichen species on colloidal bismuth subcitrate genotoxicity.
Journal: Toxicology and industrial health 20070901
Title: A proteomic approach for the identification of bismuth-binding proteins in Helicobacter pylori.
Journal: Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20070801
Title: Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Journal: Hepato-gastroenterology 20070601
Title: Nifuratel-containing initial anti-Helicobacter pylori triple therapy in children.
Journal: Helicobacter 20070401
Title: [Pharmacological efficacy of bismuth tripotassium dicitrate in peptic ulcer].
Journal: Terapevticheskii arkhiv 20070101
Title: New drugs: retapamulin, bismuth subcitrate potassium, and rotigotine.
Journal: Journal of the American Pharmacists Association : JAPhA 20070101
Title: Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection.
Journal: BMC gastroenterology 20070101
Title: Randomized comparison of two rescue therapies for Helicobacter pylori infection.
Journal: European journal of clinical investigation 20061101
Title: [Long term results of treatment by simple surgical closure of perforated gastroduodenal ulcer followed by eradication of Helicobacter pylori].
Journal: Annales de chirurgie 20061001
Title: Combinations containing amoxicillin-clavulanate and tetracycline are inappropriate for Helicobacter pylori eradication despite high in vitro susceptibility.
Journal: Journal of gastroenterology and hepatology 20061001
Title: Guidelines in the medical treatment of Helicobacter pylori infection.
Journal: Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20060901
Title: Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial.
Journal: World journal of gastroenterology 20060814
Title: Pharmacoeconomic comparison of Helicobacter pylori eradication regimens.
Journal: Pharmacy world & science : PWS 20060801
Title: Azithromycin in one week quadruple therapy for H pylori eradication in Iran.
Journal: World journal of gastroenterology 20060728
Title: Eradication of H pylori infection in a rural population: one-day quadruple therapy versus 7-day triple therapy.
Journal: World journal of gastroenterology 20060628
Title: Fabrication of bismuth subcarbonate nanotube arrays from bismuth citrate.
Journal: Chemical communications (Cambridge, England) 20060604
Title: Efficacy of one-day quadruple therapy for H pylori infection in Chinese patients.
Journal: World journal of gastroenterology 20060521
Title: Evaluation of triple and quadruple Helicobacter pylori eradication therapies in Iranian children: a randomized clinical trial.
Journal: European journal of gastroenterology & hepatology 20060501
Title: Long-term outcomes after Helicobacter pylori eradication with second-line, bismuth-containing quadruple therapy in Korea.
Journal: European journal of gastroenterology & hepatology 20060501
Title: Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial.
Journal: World journal of gastroenterology 20060321
Title: Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients.
Journal: Alimentary pharmacology & therapeutics 20060315
Title: Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
Journal: Alimentary pharmacology & therapeutics 20060201
Title: Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection.
Journal: Helicobacter 20060201
Title: Twice-a-day quadruple therapy for eradication of Helicobacter pylori in the elderly.
Journal: Helicobacter 20060201
Title: Helicobacter pylori eradication in childhood after failure of initial treatment: advantage of quadruple therapy with nifuratel to furazolidone.
Journal: Alimentary pharmacology & therapeutics 20051101
Title: Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Journal: Journal of the National Cancer Institute 20050921
Title: Acute renal failure after overdose of colloidal bismuth subcitrate.
Journal: Pediatric nephrology (Berlin, Germany) 20050901
Title: Eradication rate of Helicobacter pylori in dyspeptic patients.
Journal: Medical science monitor : international medical journal of experimental and clinical research 20050401
Title: [The effect of Helicobacter pylori eradication therapy on bismuth absorption of colloidal bismuth subcitrate].
Journal: Zhonghua nei ke za zhi 20050401
Title: Helicobacter pylori reinfection rate 3 years after successful eradication.
Journal: Journal of gastroenterology and hepatology 20050301
Title: Comparison of two management strategies for Helicobacter pylori treatment: clinical study and cost-effectiveness analysis.
Journal: Helicobacter 20050201
Title: Novel bismuth-metronidazole-tetracycline triple-layer tablet for treatment of Helicobacter pylori.
Journal: Alimentary pharmacology & therapeutics 20050115
Title: [Is anti-helicobacter therapy a rational approach in treatment of erosive and ulcerous lesions of the gastroduodenal mucosa in patients with inflamatory bowel diseases?].
Journal: Klinicheskaia meditsina 20050101
Title: [Efficacy of colloid bismuth subcitrate (De-Nol) in gastropathies induced by nonsteroid anti-inflammatory drugs: an open controlled 4-week trial].
Journal: Terapevticheskii arkhiv 20050101
Title: [New ultrashort scheme for helicobacter pylori infection eradication using tetracyline, furazolidone and colloidal bismuth subcitrate in dyspeptic patients with or without peptic ulceration in the National Hospital Cayetano Heredia].
Journal: Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 20050101
Title: Effects of bismuth citrate on the viability and function of Leydig cells and testicular macrophages.
Journal: Journal of applied toxicology : JAT 20050101
Title: [Eradication therapy of Helicobacter pylori--associated diseases: efficacy, safety, pharmacoeconomy].
Journal: Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20050101
Title: Biochemical response to colloidal bismuth subcitrate: dose-time effect.
Journal: Biological trace element research 20050101
Title: Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
Journal: Chinese journal of digestive diseases 20050101
Title: [Comparison of the effectiveness of tri- and quadricomponent eradication therapy in patients with peptic ulcer].
Journal: Klinicheskaia meditsina 20050101
Title: Long-term recurrence rate after treatment of Helicobacter pylori infection in children and adolescents in Estonia.
Journal: Scandinavian journal of gastroenterology 20041201
Title: A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20041101
Title: [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
Journal: Orvosi hetilap 20041003
Title: The effect of Helicobacter pylori eradication in patients with functional dyspepsia: assessment of different diagnostic tests.
Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20040901
Title: Total family unit Helicobacter pylori eradication and pediatric re-infection rates.
Journal: Helicobacter 20040801
Title: Inhibition of alcohol dehydrogenase by bismuth.
Journal: Journal of inorganic biochemistry 20040801
Title: Influence of omeprazole on bioavailability of bismuth following administration of a triple capsule of bismuth biskalcitrate, metronidazole, and tetracycline.
Journal: Journal of clinical pharmacology 20040601
Title: Helicobacter pylori: a historical perspective 1983-2003.
Journal: The New Zealand medical journal 20040521
Title: Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Journal: World journal of gastroenterology 20040301
Title: Bismuth citrate in the quantification of inorganic phosphate and its utility in the determination of membrane-bound phosphatases.
Journal: Analytical biochemistry 20040101
Title: Low-dose furazolidone in triple and quadruple regimens for Helicobacter pylori eradication.
Journal: Alimentary pharmacology & therapeutics 20040101
Title: [Comparative efficacy of different therapeutic schemes in gastropathies induced by nonsteroid anti-inflammatory drugs].
Journal: Terapevticheskii arkhiv 20040101
Title: Structure of colloidal bismuth subcitrate (CBS) in dilute HCl: unique assembly of bismuth citrate dinuclear units ([Bi(cit)(2)Bi](2-)).
Journal: Journal of the American Chemical Society 20031015
Title: Efficacy of different antibiotic regimens for eradication treatment of Helicobacter pylori infection in peptic ulcer disease in Tanzanian patients.
Journal: Tropical doctor 20031001
Title: Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
Journal: Archives of internal medicine 20030922
Title: The QUADRATE study: a proposal for a change in the reporting of pharmaceutical supported trials.
Journal: Gastroenterology 20030801
Title: Gastrointestinal and systemic uptake of bismuth in mice after oral exposure.
Journal: Pharmacology & toxicology 20030801
Title: Salvage therapy after two or more prior Helicobacter pylori treatment failures: the super salvage regimen.
Journal: Helicobacter 20030801
Title: A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.
Journal: Helicobacter 20030801
Title: [Failure of Helicobacter pylori eradication--suggestions for further therapy].
Journal: Orvosi hetilap 20030629
Title: [Helicobacter pylori eradication. Triple or quadruple therapy?, Long or short treatment?].
Journal: Gastroenterologia y hepatologia 20030501
Title: Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial.
Journal: The American journal of gastroenterology 20030301
Title: [Bismuth subcitrate caused acute renal failure in a child].
Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics 20030201
Title: [The state of immune system and effects of current therapy and immunomodulators].
Journal: Klinicheskaia meditsina 20030101
Title: [Effectiveness of using immunomodulators in combined treatment of patients with chronic gastritis and ulcer disease].
Journal: Klinicheskaia meditsina 20030101
Title: [Microcirculatory disorders in chronic erosions of the stomach].
Journal: Klinicheskaia meditsina 20030101
Title: In vitro evaluation of Bacopa monniera on anti-Helicobacter pylori activity and accumulation of prostaglandins.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology 20030101
Title: [Level of Helicobacter pylori infection of the gastric mucosa in the optimization of a daily dose of antihelicobacter drugs].
Journal: Klinicheskaia meditsina 20030101
Title: A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study.
Journal: Gastroenterology 20021201
Title: Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study.
Journal: European journal of gastroenterology & hepatology 20021101
Title: Does Helicobacter pylori eradication affect symptoms in nonulcer dyspepsia: a 5-year follow-up study.
Journal: Helicobacter 20021001
Title: Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection.
Journal: Alimentary pharmacology & therapeutics 20020801
Title: One-week triple vs. quadruple therapy for Helicobacter pylori infection - a randomized trial.
Journal: Alimentary pharmacology & therapeutics 20020701
Title: Furazolidone-based triple 'rescue therapy' vs. quadruple 'rescue therapy' for the eradication of Helicobacter pylori resistant to metronidazole.
Journal: Alimentary pharmacology & therapeutics 20020701
Title: Bismuth-induced lysosomal rupture in J774 cells.
Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 20020501
Title: Pathways of proximal tubular cell death in bismuth nephrotoxicity.
Journal: Toxicology and applied pharmacology 20020415
Title: Bismuth subcitrate nephrotoxicity. A reversible cause of acute oliguric renal failure.
Journal: Nephron 20020401
Title: Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection.
Journal: The American journal of gastroenterology 20020401
Title: Fanconi's syndrome, acute renal failure, and tonsil ulcerations after colloidal bismuth subcitrate intoxication.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20020301
Title: [Helicobacter heilmannii-associated gastritis].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20020201
Title: One-week quadruple therapy is an effective salvage regimen for Helicobacter pylori infection in patients after failure of standard triple therapy.
Journal: Journal of clinical gastroenterology 20020101
Title: [Changes in local humoral immunity during stomach ulcer healing with laser and drug therapy].
Journal: Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101
Title: Bismuth subcitrate/metronidazole/ tetracycline--Axcan Pharma. Bismuth triple therapy--Axcan Pharma, Helicide.
Journal: Drugs in R&D 20020101
Title: Human biokinetics of injected bismuth-207.
Journal: Human & experimental toxicology 20011201
Title: Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20011115
Title: Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults.
Journal: Gastroenterology 20011001
Title: Six-year follow-up after successful triple therapy for Helicobacter pylori infection in patients with peptic ulcer disease.
Journal: European journal of gastroenterology & hepatology 20011001
Title: Bismuth-based quadruple therapy with bismuth subcitrate, metronidazole, tetracycline and omeprazole in the eradication of Helicobacter pylori.
Journal: Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20010901
Title: Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled trial.
Journal: European journal of gastroenterology & hepatology 20010801
Title: Modified seven-day, quadruple therapy as a first line Helicobacter pylori treatment.
Journal: Alimentary pharmacology & therapeutics 20010701
Title: Helicobacter pylori and iron deficiency anaemia in children.
Journal: Scandinavian journal of gastroenterology 20010701
Title: Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study.
Journal: Alimentary pharmacology & therapeutics 20010601
Title: Reversible nephrotoxicity after overdose of colloidal bismuth subcitrate.
Journal: Pediatric nephrology (Berlin, Germany) 20010601
Title: Is eradication of Helicobacter pylori with colloidal bismuth subcitrate quadruple therapy safe?
Journal: Helicobacter 20010601
Title: Ranitidine bismuth citrate-based triple therapy for seven days, with or without further anti-secretory therapy, is highly effective in patients with duodenal ulcer and Helicobacter pylori infection.
Journal: European journal of gastroenterology & hepatology 20010501
Title: Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.
Journal: The New England journal of medicine 20010329
Title: Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials.
Journal: Annals of internal medicine 20010306
Title: Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate.
Journal: Alimentary pharmacology & therapeutics 20010301
Title: The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Journal: The Israel Medical Association journal : IMAJ 20010301
Title: Histochemical tracing of bismuth in Helicobacter pylori after in vitro exposure to bismuth citrate.
Journal: Scandinavian journal of gastroenterology 20010201
Title: Bismuth overdosing-induced reversible nephropathy in rats.
Journal: Archives of toxicology 20010201
Title: Randomized study of two 'rescue' therapies for Helicobacter pylori-infected patients after failure of standard triple therapies.
Journal: The American journal of gastroenterology 20010101
Title: Survey of dyspepsia management in community.
Journal: Singapore medical journal 20010101
Title: [Current principles of the use of laparoscopic surgery in gastroduodenal ulcer].
Journal: Khirurgiia 20010101
Title: [How to overcome antibiotic resistance of Helicobacter pylori. Role of de-nol in current schemes of eradication therapy].
Journal: Terapevticheskii arkhiv 20010101
Title: Randomized trial of a quadruple-drug regimen and a triple-drug regimen for eradication of Helicobacter pylori: long-term follow-up study.
Journal: Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20010101
Title: Second-line Helicobacter pylori eradication with a furazolidone-based regimen in patients who have failed a metronidazole-based regimen.
Journal: Digestion 20010101
Title: Solubility, absorption, and anti-Helicobacter pylori activity of bismuth subnitrate and colloidal bismuth subcitrate: In vitro data Do not predict In vivo efficacy.
Journal: Helicobacter 20000901
Title: The mode of action of colloidal bismuth subcitrate.
Journal: Scandinavian journal of gastroenterology. Supplement 19910101
Title: Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
Journal: Drugs 19880801
